Nautilus Biotechnology is based in Seattle. It has raised $445M in total funding. Latest round: IPO.
Nautilus Biotechnology funding overview
Nautilus Biotechnology is based in Seattle. Nautilus Biotechnology has raised $445M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2021. The round record for Nautilus Biotechnology runs through 2021; nothing later has been disclosed. Investors on record include Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Nautilus Biotechnology funding
How much has Nautilus Biotechnology raised?
Nautilus Biotechnology has raised $445M in total disclosed funding across the rounds on record.
Who has invested in Nautilus Biotechnology?
Andreessen Horowitz, Madrona Venture Group, AME Cloud Ventures, Vulcan Capital, Perceptive Advisors, Bezos Expeditions are named among the investors backing Nautilus Biotechnology.
What was the latest Nautilus Biotechnology funding round?
The most recent disclosed round is an IPO, announced in July 2021.
Where is Nautilus Biotechnology based?
Nautilus Biotechnology is based in Seattle.
When did Nautilus Biotechnology last raise?
The last disclosed Nautilus Biotechnology round closed in July 2021 at IPO.
Every Nautilus Biotechnology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.
